Exchange Surveillance
No active ASM or GSM measures on this stock.
Price band ± 20%
Price
Trading Data
range barsReturns
absolute and vs benchmark indexAbout the Company
Vivo Bio Tech Ltd (VBTL) is a contract research company engaged in biotechnology and pharma drug discovery activities. VBTL provides services ranging from insilico design, wet lab contract research, preclinical research and clinical studies spanning the entire drug discovery value chain.The Custom Research Services group at Vivo Bio Tech offers a complete line of protein services, including gene synthesis, cloning, expression and purification of recombinant proteins and monoclonal antibodies. In-vitro Services offers solutions for pharmacologic, toxicological & bioanalytical investigations in drug discovery & development. Critical investigations like bacterial reverse mutation assays, chromosomal aberration, and micronucleus are some of the specialty services offered by the company.
- Sector
- Healthcare
- Industry
- Biotechnology
- HQ
- Hyderabad, Telangana
- Registrar
- Aarthi Consultants Pvt Ltd
- Exchange
- NSE
- ISIN
- INE380K01017
Institutional Demand
passive ownership through ETFsContext
where this company sitsFrequently Asked
▶What is the share price of Vivo Bio Tech Ltd today?
Vivo Bio Tech Ltd (VIVOBIOT) is trading at ₹12.93. The price shown is the latest available from the exchange feed and updates through the trading session.
▶What is VIVOBIOT’s P/E ratio versus the sector?
VIVOBIOT trades at a P/E of —. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.
▶What is VIVOBIOT’s dividend yield?
VIVOBIOT has a dividend yield of 0.00%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.
▶What is VIVOBIOT’s 52-week high and low?
VIVOBIOT has traded between ₹12.07 and ₹20.44 over the past year. The Trading Data block shows where the current price sits inside that band.
▶What is the market capitalisation of Vivo Bio Tech Ltd?
Vivo Bio Tech Ltd has a market capitalisation of ₹32 crore.
▶What is VIVOBIOT’s return on equity?
VIVOBIOT reports a return on equity of -2.6%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in Biotechnology.
▶Who are VIVOBIOT’s competitors?
The Peers block on this page lists other Biotechnology companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.
▶What is VIVOBIOT’s promoter holding?
Promoters hold 30.62% of VIVOBIOT. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.
▶Which indices include VIVOBIOT?
Index membership is listed in the Context block on this page, along with the weight VIVOBIOT carries in each. That weight is what determines how much passive money tracks the stock.
▶Is Vivo Bio Tech Ltd a good buy?
We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from VIVOBIOT’s own numbers. The judgement is yours.
VIVOBIOT at a glance
Vivo Bio Tech Ltd operates in the Biotechnology industry, part of the Healthcare sector. Vivo Bio Tech Ltd (VIVOBIOT) last traded at ₹12.93, giving it a market capitalisation of ₹32 crore. The 52-week range is ₹12.07 to ₹20.44, and the price is 10% of the way up that range. Promoters hold 30.62% of the company in the latest shareholding filing.
| Market cap | ₹32 crore |
|---|---|
| ROE | -2.6% |
| ROCE | 7.7% |